Apollomics (APLM) Current Assets (2021 - 2025)
Apollomics' (APLM) quarterly Current Assets came in at $6.1 million in Q4 2025, down 41.06% year-over-year from $10.3 million in Q4 2024, and down 40.26% quarter-over-quarter from $10.1 million in Q2 2025.
Analysis
Apollomics (APLM) Current Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Current Assets for 5 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Current Assets fell 41.06% year-over-year to $6.1 million in Q4 2025; TTM through Dec 2025 was $6.1 million, a 41.06% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 41.06% from the prior year.
- Current Assets was $6.1 million for Q4 2025 at Apollomics, down from $10.1 million in the prior quarter.
- Over five years, Current Assets peaked at $55.4 million in Q2 2023 and troughed at $2.3 million in Q4 2023.
- A 5-year average of $15.6 million and a median of $8.3 million in 2021 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 340.64% in 2024 and plunged 64.35% in 2025, its largest moves.
- Over 5 years, Current Assets stood at $6.5 million in 2021, then declined by 7.48% to $6.0 million in 2022, then sank by 61.17% to $2.3 million in 2023, then jumped by 340.64% to $10.3 million in 2024, then sank by 41.06% to $6.1 million in 2025.
- The last three Current Assets figures came in at $6.1 million (Q4 2025), $10.1 million (Q2 2025), and $10.3 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | 6.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.05 Mn |
| Jun 30, 2025 | 10.13 Mn |
| Dec 31, 2024 | 10.27 Mn |
| Jun 30, 2024 | 28.41 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Jun 30, 2023 | 55.38 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 6.49 Mn |